SecureKloud Tech

- No plans for further equity dilution at present; company is not looking for additional equity fundraising. - The company aims to become debt-free by repaying promoter loans (Rs. 45 crores) over next 3 to 4 quarters; total gross debt approx. Rs. 100 crores currently. - Debt focus is on repaying non-working capital loans; will maintain only working capital debt (~Rs. 50-55 crores). - IPO funds raised (~$13 million) have been mainly deployed towards acquisition (Devcool), IPO expenses, and working capital. - Banking support and research coverage are being sought to aid next level growth but no mention of fresh debt fundraise. - Goal is to generate sufficient operating cash flow by growing recurring revenues and improving margins to reduce debt organically.

- The company has made a strategic acquisition of Devcool Inc. for $4.5 million, expanding its healthcare IT services and cloud opportunities. - Investments have been made in sales and marketing personnel (around 12 in HCTI and additional in Blockchain and SecureKloud) to drive growth. - Significant investments continue in R&D platforms to enhance offerings like CloudEz, DataEz, Readable.ai, and Blockedge. - R&D expenses peaked in the recent quarter and are expected to decrease in percentage and absolute terms over the next two quarters. - The company is exploring OEM partnerships (e.g., with Meditech) to scale Readable.ai, indicating future strategic investment in platform expansion. - No explicit mention of large new capital expenditures, but emphasis on leveraging existing platform investments for scalability. - Working capital investments increased by about Rs. 20 crores, funded partially by IPO proceeds and repayments of debt are underway.

- Guidance for FY23 expects revenue growth of 25-30% year-on-year with acceleration post-COVID due to resumed client interactions and conferences. - Long-term view targets revenue doubling every 2 years over next 10-15 years, though acknowledging recent challenges. - Goal to reach approximately Rs. 1300 crores revenue by FY25, with HCTI contributing Rs. 700-750 crores and other businesses adding 35-40%. - Emphasis on increasing recurring revenue to 60% through SaaS and platform deals, which support better margins and scalability. - Multi-year SaaS deals like Readable.ai (over $1 million recurring) enhance revenue visibility and growth potential. - Investment in expanded sales teams aimed at acquiring new clients and transitioning existing ones for growth. - Recovery and growth driven by strong pipeline, larger deal flow in healthcare and pharma IT services, and cloud/data opportunities post-COVID.

- Revenue growth guidance for FY23 is expected between 25% to 30%, reflecting acceleration post-COVID recovery and increased client engagements (Page 13). - Goal to reach Rs. 1300 crores revenue by FY25 with healthcare IT (HCTI) contributing Rs. 700-750 crores and remaining business adding 35-40% (Page 10). - Recurring revenues targeted to increase to 60% of total revenues within the next 5-6 quarters, supporting margin expansion (Page 3). - Gross margins currently around 26.5-27%; aiming to improve to about 40% in next six quarters through platform and SaaS revenue growth (Pages 11 and 11). - Bottom-line profitability focus alongside topline growth due to SaaS model with minimal incremental cost improving operating profits over time (Pages 11 and 13). - Debt reduction planned to complete within 3-4 quarters, easing interest costs and improving operational cash flows (Page 10).

- SecureKloud is currently engaged in several proposals, especially in Dubai and the Middle East through its partnership with Cognicx, expecting closures in the next 2 to 3 quarters. - The company has a healthy pipeline, particularly for its platform offerings, with expectations of substantial revenue growth in FY23. - Multiple long-term multi-year deals are in place, such as Readable.ai contracts ranging from 3 to 5 years and deal sizes between $1 million to $2 million, fully recurring over the contract period. - Ongoing engagements with large pharma customers include cloud hosting and disaster recovery services, with 60-70% of topline coming from managed services and platform opportunities. - Despite macro challenges and delayed B2B deal closures, the company views its sales investments and pipeline positively, aiming for 25-30% sequential revenue growth year-on-year. - The increase in sales force and live participation in healthcare conferences is expected to accelerate new order acquisitions going forward.